Largest Biotechnology Companies by Market Cap
Largest Biotechnology companies by market cap. The Biotechnology sector has 1,295 publicly listed stocks with a combined market cap of $2.06 Trillion. Immunome Inc leads the sector with a market cap of $2.15 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
Companies Listed
Largest Company
Top Biotechnology Stocks by Market Capitalization (October 2026)
Top Biotechnology stocks by market capitalization as of October 2026, covering 1,295 publicly listed companies.
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 151 |
Immunome Inc
NASDAQ:IMNM |
$2.15 Billion | $2.15 Billion | USA | $18.21 | -0.44% | -0.27% | 32.48 Million |
| 152 |
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
$2.14 Billion | $2.14 Billion | USA | $16.65 | -3.25% | -3.92% | 19.00 Million |
| 153 |
ADMA Biologics Inc
NASDAQ:ADMA |
$2.12 Billion | $2.12 Billion | USA | $11.41 | -2.89% | +4.20% | 67.58 Million |
| 154 |
Mesoblast Ltd
AU:MSB |
$2.07 Billion | AU$2.93 Billion | Australia | AU$2.26 | -2.59% | +23.50% | 97.23 Million |
| 155 |
Sinocelltech Group Ltd
SHG:688520 |
$2.03 Billion | CN¥13.84 Billion | China | CN¥31.08 | -1.74% | -5.22% | 61.84 Million |
| 156 |
Mesoblast Ltd
NASDAQ:MESO |
$1.97 Billion | $1.97 Billion | USA | $15.16 | -3.25% | +20.80% | 6.76 Million |
| 157 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
$1.97 Billion | $1.97 Billion | USA | $18.62 | -3.17% | +2.42% | 64.28 Million |
| 158 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
$1.95 Billion | $1.95 Billion | USA | $9.68 | -4.68% | -14.71% | 155.83 Million |
| 159 |
Jinyu Bio-Technology Co Ltd
SHG:600201 |
$1.95 Billion | CN¥13.33 Billion | China | CN¥12.12 | -3.89% | -5.24% | 343.88 Million |
| 160 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
$1.93 Billion | $1.93 Billion | USA | $26.80 | -1.18% | +5.06% | 54.86 Million |
| 161 |
Anhui Anke BioTech Group
SHE:300009 |
$1.90 Billion | CN¥12.96 Billion | China | CN¥7.76 | -0.13% | -1.40% | 495.42 Million |
| 162 |
Palvella Therapeutics, Inc
NASDAQ:PVLA |
$1.89 Billion | $1.89 Billion | USA | $146.15 | -3.58% | +15.63% | 5.71 Million |
| 163 |
Galapagos NV ADR
NASDAQ:GLPG |
$1.89 Billion | $1.89 Billion | USA | $28.68 | -1.58% | -1.65% | 4.67 Million |
| 164 |
Vir Biotechnology Inc
NASDAQ:VIR |
$1.88 Billion | $1.88 Billion | USA | $11.30 | -3.83% | +8.34% | 45.35 Million |
| 165 |
BrightGene Bio Medical Technology C
SHG:688166 |
$1.86 Billion | CN¥12.69 Billion | China | CN¥29.99 | +0.40% | -2.31% | 210.95 Million |
| 166 |
Generate Biomedicines, Inc. Common Stock
NASDAQ:GENB |
$1.86 Billion | $1.86 Billion | USA | $14.46 | -8.31% | +13.06% | 25.13 Million |
| 167 |
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO |
$1.85 Billion | $1.85 Billion | USA | $28.39 | -1.29% | +0.57% | 13.62 Million |
| 168 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
$1.84 Billion | $1.84 Billion | USA | $4.03 | -4.95% | +12.57% | 717.34 Million |
| 169 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
$1.83 Billion | $1.83 Billion | USA | $13.56 | -1.81% | +4.79% | 62.77 Million |
| 170 |
Agios Pharm
NASDAQ:AGIO |
$1.82 Billion | $1.82 Billion | USA | $30.55 | -17.94% | -17.85% | 27.71 Million |
| 171 |
ZAI LAB LTD0000006
F:1ZLB |
$1.82 Billion | €1.56 Billion | Germany | €1.98 | -1.00% | -1.98% | 17.92K |
| 172 |
ADARx Pharmaceuticals, Inc. Common Stock
NASDAQ:ADRX |
$1.82 Billion | $1.82 Billion | USA | $17.00 | -4.76% | -3.85% | 11.58 Million |
| 173 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
$1.79 Billion | $1.79 Billion | USA | $28.61 | -0.35% | +0.60% | 27.24 Million |
| 174 |
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX |
$1.76 Billion | $1.76 Billion | USA | $55.87 | +2.44% | +10.72% | 13.65 Million |
| 175 |
Gempharmatech Co. Ltd. A
SHG:688046 |
$1.76 Billion | CN¥12.00 Billion | China | CN¥29.28 | +2.09% | +5.40% | 245.60 Million |
| 176 |
Lakefront Biotherapeutics NV
NASDAQ:LKFT |
$1.76 Billion | $1.76 Billion | USA | $26.81 | +0.00% | -6.94% | 5.95 Million |
| 177 |
SK Bioscience Co Ltd
KO:302440 |
$1.74 Billion | ₩2.57 Trillion | Korea | ₩32750.00 | +1.71% | -5.35% | 1.67 Million |
| 178 |
Vericel Corp Ord
NASDAQ:VCEL |
$1.73 Billion | $1.73 Billion | USA | $40.26 | -6.18% | -6.31% | 13.33 Million |
| 179 |
Braveheart Bio, Inc. Common Stock
NASDAQ:BRVE |
$1.72 Billion | $1.72 Billion | USA | $21.51 | +1.51% | +0.14% | 9.23 Million |
| 180 |
REMEGEN CO. LTD YC 1
F:REG |
$1.71 Billion | €1.47 Billion | Germany | €7.03 | -2.82% | -0.82% | 0.00 |
| 181 |
Viridian Therapeutics Inc
NASDAQ:VRDN |
$1.71 Billion | $1.71 Billion | USA | $24.67 | -0.52% | +8.11% | 48.80 Million |
| 182 |
Nanjing Vazyme Biotech Co Ltd
SHG:688105 |
$1.71 Billion | CN¥11.67 Billion | China | CN¥22.58 | +3.01% | +7.06% | 365.04 Million |
| 183 |
Neuren Pharmaceuticals Ltd
AU:NEU |
$1.70 Billion | AU$2.40 Billion | Australia | AU$20.36 | +1.09% | +2.78% | 7.74 Million |
| 184 |
Stoke Therapeutics Inc
NASDAQ:STOK |
$1.70 Billion | $1.70 Billion | USA | $26.29 | -0.23% | +2.30% | 25.77 Million |
| 185 |
RAPT Therapeutics Inc
NASDAQ:RAPT |
$1.68 Billion | $1.68 Billion | USA | $58.01 | +0.00% | +0.13% | 98.79 Million |
| 186 |
PHARVARIS N.V. EO -12
F:9EN |
$1.67 Billion | €1.43 Billion | Germany | €29.50 | +1.72% | +8.46% | 0.00 |
| 187 |
Nuvation Bio Inc
NYSE:NUVB |
$1.67 Billion | $1.67 Billion | USA | $4.76 | -0.21% | +1.28% | 135.06 Million |
| 188 |
Septerna, Inc. Common Stock
NASDAQ:SEPN |
$1.64 Billion | $1.64 Billion | USA | $44.00 | -2.72% | +7.63% | 9.06 Million |
| 189 |
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS |
$1.61 Billion | $1.61 Billion | USA | $18.18 | -14.41% | -15.32% | 36.78 Million |
| 190 |
UroGen Pharma Ltd
NASDAQ:URGN |
$1.60 Billion | $1.60 Billion | USA | $32.72 | -2.27% | -6.91% | 25.01 Million |
| 191 |
Galapagos NV
F:GXEA |
$1.60 Billion | €1.37 Billion | Germany | €28.80 | +0.70% | +7.46% | 0.00 |
| 192 |
Nanobiotix
NASDAQ:NBTX |
$1.59 Billion | $1.59 Billion | USA | $31.37 | -7.19% | +7.47% | 3.59 Million |
| 193 |
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
$1.57 Billion | CN¥10.73 Billion | China | CN¥18.75 | -0.21% | -1.42% | 36.05 Million |
| 194 |
Mesoblast Limited
F:LWB |
$1.56 Billion | €1.34 Billion | Germany | €1.36 | -2.61% | +24.05% | 6.00K |
| 195 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
$1.56 Billion | $1.56 Billion | USA | $21.87 | -0.32% | -0.27% | 29.78 Million |
| 196 |
Galapagos N.V.
AS:GLPG |
$1.55 Billion | €1.33 Billion | Netherlands | €26.90 | +4.67% | +13.22% | 1.67 Million |
| 197 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
$1.53 Billion | $1.53 Billion | USA | $6.97 | -4.65% | +5.45% | 81.29 Million |
| 198 |
Innoviva Inc
NASDAQ:INVA |
$1.53 Billion | $1.53 Billion | USA | $21.22 | -0.42% | +0.76% | 15.75 Million |
| 199 |
LegoChem Biosciences Inc
KQ:141080 |
$1.52 Billion | ₩2.24 Trillion | Korea | ₩61500.00 | -3.91% | -11.38% | 4.87 Million |
| 200 |
Shanghai Medicilon Inc
SHG:688202 |
$1.50 Billion | CN¥10.27 Billion | China | CN¥76.42 | -0.25% | -1.90% | 148.70 Million |
| 201 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
$1.50 Billion | $1.50 Billion | USA | $30.49 | -2.49% | -5.07% | 12.65 Million |
| 202 |
First Tracks Biotherapeutics
NASDAQ:TRAX |
$1.49 Billion | $1.49 Billion | USA | $45.08 | -0.32% | +4.50% | 26.52 Million |
| 203 |
Pharma Reaserch Prod Co Ltd
KQ:214450 |
$1.49 Billion | ₩2.20 Trillion | Korea | ₩212000.00 | -4.72% | -16.86% | 2.41 Million |
| 204 |
ABL Bio Inc
KQ:298380 |
$1.49 Billion | ₩2.19 Trillion | Korea | ₩39200.00 | -4.39% | -11.91% | 7.48 Million |
| 205 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
$1.47 Billion | $1.47 Billion | USA | $12.47 | -5.74% | +11.74% | 131.24 Million |
| 206 |
Galecto Inc
NASDAQ:GLTO |
$1.47 Billion | $1.47 Billion | USA | $24.45 | +1.33% | -4.72% | 7.16 Million |
| 207 |
uniQure N.V
F:UQ1 |
$1.46 Billion | €1.25 Billion | Germany | €22.15 | -1.56% | +12.67% | 3.58K |
| 208 |
Uniqure NV
NASDAQ:QURE |
$1.46 Billion | $1.46 Billion | USA | $24.83 | -1.86% | +7.44% | 76.44 Million |
| 209 |
Inner Mongolia Furui Med Sci
SHE:300049 |
$1.46 Billion | CN¥9.96 Billion | China | CN¥37.72 | -2.28% | -1.95% | 146.30 Million |
| 210 |
GH Research PLC
NASDAQ:GHRS |
$1.43 Billion | $1.43 Billion | USA | $20.86 | -2.98% | +12.76% | 8.34 Million |
| 211 |
AnaptysBio Inc
NASDAQ:ANAB |
$1.43 Billion | $1.43 Billion | USA | $48.28 | -0.74% | +0.37% | 13.06 Million |
| 212 |
Ultragenyx
NASDAQ:RARE |
$1.41 Billion | $1.41 Billion | USA | $16.10 | -4.05% | +0.94% | 85.64 Million |
| 213 |
Concord Biotech Limited
NSE:CONCORDBIO |
$1.41 Billion | Rs130.31 Billion | India | Rs1245.60 | +1.22% | -1.98% | 2.71 Million |
| 214 |
Absci Corp
NASDAQ:ABSI |
$1.41 Billion | $1.41 Billion | USA | $11.13 | -8.02% | +18.78% | 98.35 Million |
| 215 |
Nanobiotix S.A
PA:NANO |
$1.39 Billion | €1.19 Billion | France | €28.12 | -7.26% | +8.49% | 5.86 Million |
| 216 |
Pharma Mar S.A.
MC:PHM |
$1.37 Billion | €1.17 Billion | Spain | €67.50 | -2.53% | -4.53% | 705.07K |
| 217 |
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE |
$1.37 Billion | $1.37 Billion | USA | $31.48 | -1.41% | -1.47% | 18.09 Million |
| 218 |
IMMUNOCORE HLDGS ADS/1
F:6YG |
$1.36 Billion | €1.16 Billion | Germany | €24.80 | -1.59% | -7.46% | 4.72K |
| 219 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
$1.35 Billion | $1.35 Billion | USA | $4.13 | -2.13% | +3.12% | 89.73 Million |
| 220 |
Omeros Corporation
NASDAQ:OMER |
$1.33 Billion | $1.33 Billion | USA | $18.44 | -2.69% | +9.37% | 27.67 Million |
| 221 |
Nektar Therapeutics
NASDAQ:NKTR |
$1.33 Billion | $1.33 Billion | USA | $38.87 | -0.79% | +0.57% | 30.41 Million |
| 222 |
Damora Therapeutics, Inc.
NASDAQ:DMRA |
$1.33 Billion | $1.33 Billion | USA | $21.49 | -2.36% | -1.01% | 11.01 Million |
| 223 |
Staidson Beijing Biopharma
SHE:300204 |
$1.33 Billion | CN¥9.06 Billion | China | CN¥16.73 | -1.47% | -3.29% | 289.17 Million |
| 224 |
Kardigan, Inc. Common Stock
NASDAQ:KARD |
$1.32 Billion | $1.32 Billion | USA | $14.13 | -1.26% | +10.91% | 14.46 Million |
| 225 |
Hugel Inc
KQ:145020 |
$1.32 Billion | ₩1.94 Trillion | Korea | ₩179800.00 | -1.91% | -0.55% | 1.20 Million |
| 226 |
Novavax Inc
NASDAQ:NVAX |
$1.31 Billion | $1.31 Billion | USA | $10.08 | -3.72% | +0.90% | 197.75 Million |
| 227 |
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
$1.31 Billion | CN¥8.93 Billion | China | CN¥9.40 | +0.21% | -1.26% | 133.67 Million |
| 228 |
Kailera Therapeutics, Inc. Common Stock
NASDAQ:KLRA |
$1.30 Billion | $1.30 Billion | USA | $12.86 | -4.10% | -3.09% | 30.05 Million |
| 229 |
OliX PharmaceuticalsInc
KQ:226950 |
$1.29 Billion | ₩1.91 Trillion | Korea | ₩94000.00 | -2.59% | -10.98% | 5.26 Million |
| 230 |
ATAI LIFE SCIENCES BV EO1
F:9VC |
$1.29 Billion | €1.10 Billion | Germany | €3.55 | +0.00% | +4.76% | 69.10K |
| 231 |
ATAI Life Sciences NV
XETRA:9VC |
$1.27 Billion | €1.09 Billion | Germany | €3.43 | -1.21% | -2.89% | 99.02K |
| 232 |
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
$1.24 Billion | CN¥8.47 Billion | China | CN¥26.72 | -1.11% | -1.76% | 39.38 Million |
| 233 |
Tourmaline Bio Inc.
NASDAQ:TRML |
$1.23 Billion | $1.23 Billion | USA | $47.98 | +0.00% | +0.00% | 0.00 |
| 234 |
Chengzhi Shareholding Co Ltd
SHE:000990 |
$1.23 Billion | CN¥8.39 Billion | China | CN¥4.93 | -2.38% | -12.28% | 628.00 Million |
| 235 |
GH RESEARCH PLC DL-025
F:1KA |
$1.22 Billion | €1.05 Billion | Germany | €18.90 | +8.00% | +12.50% | 500.00 |
| 236 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
$1.22 Billion | $1.22 Billion | USA | $13.65 | -3.53% | +0.59% | 61.87 Million |
| 237 |
NANOBIOTIX S.A. SP.ADR
F:5NRA |
$1.21 Billion | €1.04 Billion | Germany | €27.40 | +2.24% | -0.72% | 421.00 |
| 238 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
$1.20 Billion | $1.20 Billion | USA | $25.05 | +3.47% | -5.58% | 29.36 Million |
| 239 |
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645 |
$1.18 Billion | CN¥8.08 Billion | China | CN¥17.27 | +0.12% | -1.65% | 195.44 Million |
| 240 |
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG |
$1.17 Billion | $1.17 Billion | USA | $41.45 | +2.55% | +19.06% | 10.89 Million |
| 241 |
EVEREST MED.LTD DL-0001
F:6HN |
$1.16 Billion | €996.28 Million | Germany | €3.02 | -7.93% | -23.35% | 0.00 |
| 242 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
$1.16 Billion | $1.16 Billion | USA | $7.81 | -7.68% | +10.47% | 60.91 Million |
| 243 |
immatics biotechnologies GmbH
F:4A3 |
$1.15 Billion | €984.90 Million | Germany | €6.47 | -0.77% | -4.71% | 10.59K |
| 244 |
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN |
$1.14 Billion | $1.14 Billion | USA | $25.63 | -0.31% | -5.94% | 9.64 Million |
| 245 |
Tyra Biosciences Inc
NASDAQ:TYRA |
$1.13 Billion | $1.13 Billion | USA | $21.07 | -1.91% | +0.96% | 15.71 Million |
| 246 |
Vor Biopharma Inc
NASDAQ:VOR |
$1.13 Billion | $1.13 Billion | USA | $19.68 | -5.88% | +3.91% | 20.20 Million |
| 247 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
$1.13 Billion | $1.13 Billion | USA | $21.53 | +0.00% | +0.37% | 36.16 Million |
| 248 |
MannKind Corp
NASDAQ:MNKD |
$1.13 Billion | $1.13 Billion | USA | $3.50 | +0.00% | +9.37% | 101.25 Million |
| 249 |
Aurisco Pharmaceutical Co Ltd
SHG:605116 |
$1.09 Billion | CN¥7.42 Billion | China | CN¥18.26 | +0.61% | -0.71% | 44.13 Million |
| 250 |
180 Life Sciences Corp
NASDAQ:ATNF |
$1.08 Billion | $1.08 Billion | USA | $16.80 | +0.00% | +0.00% | 497.55K |
| 251 |
HBM HLDGS LTD DL-000025
F:6XY |
$1.07 Billion | €914.17 Million | Germany | €1.09 | -0.91% | -3.54% | 0.00 |
| 252 |
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
$1.06 Billion | CN¥7.27 Billion | China | CN¥5.18 | -1.71% | -3.00% | 658.57 Million |
| 253 |
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513 |
$1.06 Billion | CN¥7.25 Billion | China | CN¥41.05 | -1.72% | -8.88% | 45.30 Million |
| 254 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
$1.05 Billion | $1.05 Billion | USA | $71.78 | -2.54% | -26.08% | 6.70 Million |
| 255 |
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX |
$1.05 Billion | $1.05 Billion | USA | $19.60 | -7.11% | -5.59% | 5.52 Million |
| 256 |
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497 |
$1.05 Billion | CN¥7.15 Billion | China | CN¥13.28 | -1.92% | -4.87% | 827.78 Million |
| 257 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
$1.03 Billion | $1.03 Billion | USA | $8.48 | -11.30% | -40.03% | 428.97 Million |
| 258 |
Idorsia Ltd
SW:IDIA |
$1.03 Billion | CHF814.02 Million | Switzerland | CHF4.47 | -2.44% | +5.52% | 19.35 Million |
| 259 |
Seegene Inc
KQ:096530 |
$1.03 Billion | ₩1.52 Trillion | Korea | ₩33250.00 | -1.04% | -3.48% | 6.93 Million |
| 260 |
PATTIES FOODS
F:PH4 |
$1.01 Billion | €863.03 Million | Germany | €0.54 | +3.85% | -2.28% | 128.00 |
| 261 |
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294 |
$1.01 Billion | CN¥6.87 Billion | China | CN¥13.63 | -1.73% | -1.16% | 106.90 Million |
| 262 |
Ventyx Biosciences Inc
NASDAQ:VTYX |
$1.00 Billion | $1.00 Billion | USA | $14.00 | +0.00% | +0.29% | 71.70 Million |
| 263 |
MoonLake Immunotherapeutics
NASDAQ:MLTX |
$1.00 Billion | $1.00 Billion | USA | $11.78 | -6.28% | -4.54% | 46.25 Million |
| 264 |
Verve Therapeutics Inc
NASDAQ:VERV |
$994.04 Million | $994.04 Million | USA | $11.13 | +0.00% | +0.00% | 0.00 |
| 265 |
Bio-Thera Solutions Ltd
SHG:688177 |
$991.30 Million | CN¥6.77 Billion | China | CN¥16.36 | -3.37% | -5.65% | 114.33 Million |
| 266 |
Savara Inc
NASDAQ:SVRA |
$990.32 Million | $990.32 Million | USA | $4.82 | -2.63% | +6.17% | 62.00 Million |
| 267 |
Gracell Biotechnologies Inc.
NASDAQ:GRCL |
$989.87 Million | $989.87 Million | USA | $562.10 | +0.20% | -4.73% | 53.25K |
| 268 |
Starlake Bioscience Co Inc Zhaoqing Guangdong
SHG:600866 |
$989.52 Million | CN¥6.76 Billion | China | CN¥4.07 | -0.49% | +1.75% | 503.08 Million |
| 269 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
$957.75 Million | $957.75 Million | USA | $9.24 | +2.78% | -32.21% | 44.44 Million |
| 270 |
INVENTIVA ADS/1 O.N.
F:6IVA |
$957.19 Million | €818.74 Million | Germany | €4.38 | -0.45% | -2.23% | 102.00 |
| 271 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
$948.95 Million | $948.95 Million | USA | $21.29 | -7.97% | -10.99% | 47.39 Million |
| 272 |
Blue Jet Healthcare Limited
NSE:BLUEJET |
$946.52 Million | Rs87.52 Billion | India | Rs504.55 | +0.20% | +3.45% | 7.30 Million |
| 273 |
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
$935.10 Million | CN¥6.39 Billion | China | CN¥46.65 | -2.00% | -3.91% | 27.29 Million |
| 274 |
Latigo Biotherapeutics, Inc. Common Stock
NASDAQ:LTGO |
$924.88 Million | $924.88 Million | USA | $13.95 | -10.23% | -15.81% | 6.91 Million |
| 275 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
$917.97 Million | $917.97 Million | USA | $10.76 | -1.01% | -3.15% | 36.79 Million |
| 276 |
Obsidian Therapeutics, Inc. Common Stock
NASDAQ:OBX |
$913.62 Million | $913.62 Million | USA | $14.79 | +1.86% | +6.10% | 7.92 Million |
| 277 |
Kura Oncology Inc
NASDAQ:KURA |
$912.74 Million | $912.74 Million | USA | $10.26 | -2.84% | +4.06% | 40.31 Million |
| 278 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
$911.45 Million | $911.45 Million | USA | $9.49 | -2.22% | -2.87% | 20.14 Million |
| 279 |
Chengdu Kanghua Biological Products
SHE:300841 |
$909.69 Million | CN¥6.22 Billion | China | CN¥47.84 | +0.38% | +1.57% | 68.69 Million |
| 280 |
Beijing Hotgen Biotech Co Ltd
SHG:688068 |
$907.98 Million | CN¥6.20 Billion | China | CN¥66.93 | -4.78% | -4.52% | 61.07 Million |
| 281 |
Cullinan Oncology LLC
NASDAQ:CGEM |
$894.21 Million | $894.21 Million | USA | $15.03 | -2.72% | +0.74% | 19.44 Million |
| 282 |
Jade Biosciences, Inc.
NASDAQ:JBIO |
$894.18 Million | $894.18 Million | USA | $14.06 | -1.26% | -5.70% | 21.29 Million |
| 283 |
Pharming Group NV
AS:PHARM |
$887.40 Million | €759.04 Million | Netherlands | €1.09 | +0.79% | +15.49% | 228.83 Million |
| 284 |
CureVac NV
F:5CV |
$885.32 Million | €757.26 Million | Germany | €3.91 | -0.61% | +10.78% | 458.08K |
| 285 |
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
$883.29 Million | CN¥6.04 Billion | China | CN¥7.27 | +0.83% | -0.95% | 174.62 Million |
| 286 |
Rigel Pharmaceuticals Inc
NASDAQ:RIGL |
$882.44 Million | $882.44 Million | USA | $51.31 | -0.27% | +5.01% | 4.99 Million |
| 287 |
Janux Therapeutics Inc
NASDAQ:JANX |
$878.78 Million | $878.78 Million | USA | $17.47 | -2.02% | +2.40% | 18.44 Million |
| 288 |
Alumis Inc
NASDAQ:ALMS |
$871.10 Million | $871.10 Million | USA | $6.73 | -2.32% | -1.32% | 49.07 Million |
| 289 |
Odyssey Therapeutics, Inc. Common Stock
NASDAQ:ODTX |
$870.82 Million | $870.82 Million | USA | $19.54 | -1.46% | +2.41% | 5.91 Million |
| 290 |
Pharming Group NV
NASDAQ:PHAR |
$863.75 Million | $863.75 Million | USA | $12.23 | +0.82% | +14.62% | 345.48K |
| 291 |
Theravance Biopharma Inc
NASDAQ:TBPH |
$854.78 Million | $854.78 Million | USA | $17.03 | +0.00% | -0.06% | 24.26 Million |
| 292 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
$843.73 Million | $843.73 Million | USA | $10.03 | -1.96% | -5.82% | 25.64 Million |
| 293 |
Silence Therapeutics PLC
NASDAQ:SLN |
$842.19 Million | $842.19 Million | USA | $19.75 | -0.25% | +0.46% | 121.64 Million |
| 294 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
$834.03 Million | $834.03 Million | USA | $4.21 | -1.64% | +0.00% | 121.55 Million |
| 295 |
Theravance Biopharma Inc
F:0TB |
$828.57 Million | €708.72 Million | Germany | €14.70 | +0.00% | +0.68% | 718.00 |
| 296 |
Xencor Inc
NASDAQ:XNCR |
$827.65 Million | $827.65 Million | USA | $29.82 | +2.09% | +15.40% | 40.73 Million |
| 297 |
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
$826.89 Million | CN¥5.65 Billion | China | CN¥37.84 | +0.83% | -0.68% | 63.17 Million |
| 298 |
SpyGlass Pharma, Inc.
NASDAQ:SGP |
$823.49 Million | $823.49 Million | USA | $32.24 | -0.83% | +14.25% | 2.10 Million |
| 299 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
$820.37 Million | $820.37 Million | USA | $27.00 | +0.00% | +0.19% | 70.92 Million |
| 300 |
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS |
$806.85 Million | $806.85 Million | USA | $15.93 | -5.46% | -4.95% | 7.81 Million |
How Biotechnology Companies Are Ranked by Market Cap
Biotechnology companies are ranked by market cap, the latest share price multiplied by shares outstanding, with each company counted once at its primary listing.
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries